With new $910M fund, Clarus aims to bankroll Big Pharma’s R&D
July 18, 2017 at 07:00 AM EDT
The venture capital firm, which has offices in Cambridge and San Francisco, is continuing its strategy of investing in late-stage trials of promising drugs.
